Him and her (NYSE: HIM) announced this week that it is entering the nutrition business with bars and shakes. But are these the right products to add to a pharmaceutical company? Travis Hoium breaks down the news and how it fits into Hims & Hers’ business in this video.

*Stock prices used are closing prices on November 21, 2024. The video was published on November 21, 2024.

Should you invest $1,000 in Hims & Hers Health right now?

Before buying Hims & Hers Health stock, consider this:

THE Motley Fool Stock Advisor The analyst team has just identified what they think is the 10 best stocks for investors to buy now…and Hims & Hers Health was not one of them. The 10 selected stocks could produce monster returns in the years to come.

Consider when Nvidia made this list on April 15, 2005…if you had invested $1,000 at the time of our recommendation, you would have $898,809!*

Equity Advisor provides investors with an easy-to-follow plan for success, including portfolio building advice, regular analyst updates, and two new stock picks each month. THE Equity Advisor the service has more than quadrupled the return of the S&P 500 since 2002*.

See the 10 values ​​»

*Stock Advisor returns November 18, 2024

Travis Hoium holds positions in Hims & Hers Health. The Motley Fool has no position in any of the securities mentioned. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe via their link they will earn extra money to support their channel. Their opinions remain their own and are not affected by The Motley Fool.